Melvin G Lee, MD
Dermatology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A108721 · Current
Licensed to practise in California · since 2009 · expires 2027-07-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Drugs they prescribed that Part D paid
$435,690
Pharmacies billed $435,690 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 763) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
643 generic and 120 brand-name prescriptions · $435,690 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cosentyx Sensoready (2 Pens) | 26 | $85,492 | $3,288 |
| Cosentyx (2 Syringes) | 14 | $55,135 | $3,938 |
| Cordran | 12 | $9,533 | $794 |
| Vectical | 38 | $7,141 | $188 |
| Tacrolimus | 73 | $5,842 | $80 |
See all 16 drugs
| Cosentyx Sensoready (2 Pens) | 26 | $85,492 | $3,288 |
| Cosentyx (2 Syringes) | 14 | $55,135 | $3,938 |
| Cordran | 12 | $9,533 | $794 |
| Vectical | 38 | $7,141 | $188 |
| Tacrolimus | 73 | $5,842 | $80 |
| Calcipotriene | 31 | $4,335 | $140 |
| Clobetasol Propionate | 161 | $4,303 | $27 |
| Betamethasone Diprop Augmented | 45 | $2,706 | $60 |
| Fluorouracil | 55 | $2,091 | $38 |
| Acitretin | 11 | $1,419 | $129 |
| Triamcinolone Acetonide | 73 | $1,354 | $19 |
| Hydrocortisone | 51 | $680 | $13 |
| Metronidazole | 28 | $544 | $19 |
| Fluocinonide | 15 | $396 | $26 |
| Methotrexate | 16 | $229 | $14 |
| Mupirocin | 12 | $139 | $12 |
Year by year
| 2024 | 763 | 253 | 0% (0) | 16% | $435,690 |
| 2023 | 728 | 275 | 0% (0) | 19% | $371,410 |
| 2022 | 684 | 263 | 0% (0) | 17% | $279,803 |
| 2021 | 608 | 232 | 0% (0) | 19% | $342,721 |
| 2020 | 408 | 180 | 0% (0) | 19% | $206,164 |
| 2019 | 458 | 184 | 0% (0) | 23% | $215,689 |
| 2018 | 482 | 197 | 0% (0) | 44% | $224,146 |
| 2017 | 431 | 173 | 0% (0) | 54% | $213,954 |
| 2016 | 486 | 217 | 0% (0) | 47% | $177,192 |
| 2015 | 430 | 187 | 0% (0) | 28% | $117,197 |
| 2014 | 426 | 174 | 0% (0) | 27% | $67,462 |
| 2013 | 441 | 169 | 0% (0) | None | $54,863 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Cosentyx (2 Syringes) | 18 | $77,889 | $4,327 |
| Cosentyx Sensoready (2 Pens) | 23 | $76,319 | $3,318 |
| Vectical | 54 | $10,325 | $191 |
| Tacrolimus | 59 | $4,375 | $74 |
| Fluorouracil | 92 | $3,637 | $40 |
| Clobetasol Propionate | 132 | $3,530 | $27 |
| Betamethasone Diprop Augmented | 49 | $2,901 | $59 |
| Triamcinolone Acetonide | 87 | $2,047 | $24 |
| Hydrocortisone | 57 | $756 | $13 |
| Fluocinonide | 15 | $547 | $36 |
| Metronidazole | 18 | $366 | $20 |
2022: 11 drugs
| Tremfya | 12 | $112,505 | $9,375 |
| Otezla | 12 | $45,468 | $3,789 |
| Cosentyx Pen (2 Pens) | 15 | $36,537 | $2,436 |
| Vectical | 40 | $7,728 | $193 |
| Clobetasol Propionate | 139 | $5,957 | $43 |
| Fluorouracil | 89 | $5,062 | $57 |
| Tacrolimus | 45 | $4,478 | $100 |
| Betamethasone Diprop Augmented | 69 | $3,802 | $55 |
| Triamcinolone Acetonide | 85 | $1,971 | $23 |
| Fluocinonide | 21 | $986 | $47 |
| Hydrocortisone | 53 | $760 | $14 |
2021: 12 drugs
| Tremfya | 11 | $99,780 | $9,071 |
| Cosentyx Pen (2 Pens) | 22 | $73,141 | $3,325 |
| Clobetasol Propionate | 114 | $7,388 | $65 |
| Vectical | 44 | $6,941 | $158 |
| Tacrolimus | 39 | $4,387 | $112 |
| Betamethasone Diprop Augmented | 58 | $4,325 | $75 |
| Fluorouracil | 64 | $3,700 | $58 |
| Triamcinolone Acetonide | 95 | $2,134 | $22 |
| Metronidazole | 15 | $857 | $57 |
| Fluocinonide | 15 | $759 | $51 |
| Hydrocortisone | 50 | $729 | $15 |
| Methotrexate | 19 | $243 | $13 |
2020: 10 drugs
| Tremfya | 13 | $113,190 | $8,707 |
| Betamethasone Diprop Augmented | 80 | $5,718 | $71 |
| Clobetasol Propionate | 55 | $3,828 | $70 |
| Vectical | 18 | $2,940 | $163 |
| Fluorouracil | 45 | $2,906 | $65 |
| Tacrolimus | 21 | $2,391 | $114 |
| Metronidazole | 12 | $862 | $72 |
| Fluocinonide | 13 | $771 | $59 |
| Triamcinolone Acetonide | 48 | $632 | $13 |
| Hydrocortisone | 20 | $286 | $14 |
2019: 11 drugs
| Humira | 16 | $64,859 | $4,054 |
| Betamethasone Diprop Augmented | 136 | $8,221 | $60 |
| Acitretin | 12 | $3,922 | $327 |
| Vectical | 27 | $3,772 | $140 |
| Clobetasol Propionate | 32 | $2,912 | $91 |
| Fluorouracil | 38 | $2,883 | $76 |
| Tacrolimus | 12 | $1,558 | $130 |
| Metronidazole | 16 | $968 | $60 |
| Fluocinonide | 13 | $967 | $74 |
| Triamcinolone Acetonide | 53 | $787 | $15 |
| Hydrocortisone | 30 | $462 | $15 |
2018: 9 drugs
| Humira | 21 | $82,794 | $3,943 |
| Betamethasone Diprop Augmented | 152 | $20,705 | $136 |
| Fluorouracil | 65 | $10,582 | $163 |
| Vectical | 47 | $5,576 | $119 |
| Tacrolimus | 13 | $2,244 | $173 |
| Clobetasol Propionate | 14 | $1,550 | $111 |
| Triamcinolone Acetonide | 49 | $1,350 | $28 |
| Fluocinonide | 11 | $815 | $74 |
| Hydrocortisone | 27 | $422 | $16 |
2017: 10 drugs
| Humira | 14 | $51,749 | $3,696 |
| Betamethasone Dipropionate | 116 | $14,847 | $128 |
| Fluorouracil | 59 | $10,008 | $170 |
| Tacrolimus | 17 | $6,659 | $392 |
| Vectical | 44 | $6,369 | $145 |
| Clobetasol Propionate | 19 | $2,271 | $120 |
| Metronidazole | 14 | $1,804 | $129 |
| Fluocinonide | 14 | $1,248 | $89 |
| Triamcinolone Acetonide | 27 | $939 | $35 |
| Hydrocortisone | 31 | $503 | $16 |
2016: 11 drugs
| Humira | 15 | $50,568 | $3,371 |
| Betamethasone Dipropionate | 88 | $11,463 | $130 |
| Clobetasol Propionate | 45 | $10,999 | $244 |
| Tacrolimus | 22 | $8,222 | $374 |
| Fluorouracil | 67 | $7,624 | $114 |
| Vectical | 44 | $5,561 | $126 |
| Metronidazole | 18 | $2,295 | $127 |
| Fluocinonide | 17 | $1,593 | $94 |
| Triamcinolone Acetonide | 53 | $1,395 | $26 |
| Hydrocortisone | 51 | $1,069 | $21 |
| Imiquimod | 12 | $560 | $47 |
2015: 10 drugs
| Clobetasol Propionate | 136 | $32,068 | $236 |
| Humira | 11 | $28,637 | $2,603 |
| Calcipotriene | 16 | $14,801 | $925 |
| Tacrolimus | 29 | $9,878 | $341 |
| Vectical | 40 | $6,348 | $159 |
| Fluorouracil | 24 | $2,760 | $115 |
| Fluocinonide | 24 | $2,221 | $93 |
| Metronidazole | 16 | $1,839 | $115 |
| Triamcinolone Acetonide | 36 | $998 | $28 |
| Hydrocortisone | 41 | $818 | $20 |
2014: 10 drugs
| Protopic | 39 | $16,056 | $412 |
| Calcipotriene | 18 | $14,438 | $802 |
| Acitretin | 11 | $11,651 | $1,059 |
| Clobetasol Propionate | 118 | $5,158 | $44 |
| Vectical | 28 | $4,479 | $160 |
| Fluorouracil | 31 | $3,483 | $112 |
| Metronidazole | 16 | $1,769 | $111 |
| Triamcinolone Acetonide | 33 | $1,205 | $37 |
| Fluocinonide | 22 | $748 | $34 |
| Hydrocortisone | 20 | $388 | $19 |
2013: 10 drugs
| Protopic | 35 | $12,629 | $361 |
| Vectical | 30 | $3,389 | $113 |
| Metronidazole | 22 | $3,116 | $142 |
| Fluorouracil | 19 | $3,059 | $161 |
| Clobetasol Propionate | 91 | $2,545 | $28 |
| Fluocinonide | 36 | $1,425 | $40 |
| Gengraf | 11 | $1,423 | $129 |
| Triamcinolone Acetonide | 36 | $1,178 | $33 |
| Hydrocortisone | 39 | $925 | $24 |
| Retin-A | 15 | $607 | $40 |
Money from drug and device companies
$357 in 2019
A payment is not proof that care is biased.
| Celgene | Otezla | $142 | 2 payments
|
| Amgen | Enbrel | $125 | 1 payment
|
| Galderma Laboratories L.P. | Oracea | $48 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $42 | 1 payment
|
See all 5 published payments
| Galderma Laboratories L.P. | Meals · 2019-10-19 | Oracea | $48 |
| Celgene | Meals · 2019-10-18 | None | $91 |
| Celgene | Meals · 2019-10-18 | Otezla | $51 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2019-10-17 | Siliq | $42 |
| Amgen | Meals · 2019-09-26 | Enbrel | $125 |
Professional record
- NPI
- 1124283056
- Licence
- CA A108721California A108721: Current · expires 2027-07-31
- Trained
- R Franklin University of Med & Sci/Chicago Medical School, 2005
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Federal specialty code 207NP0225X (207NP0225X); Federal specialty code 207NS0135X (207NS0135X)
- Mailing address
- 710 Lawrence Expy, Dermatology, Dept 472, Santa Clara, CA, 95051
- NPI first listed
- 2008-07-21
- NPI last updated
- 2021-12-13
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.